Vistagen Therapeutics, Inc. · NASDAQ:VTGN

BVF PARTNERS L P/IL reported a 9.97% stake in Vistagen Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

BVF PARTNERS L P/IL reported a 9.97% stake in Vistagen Therapeutics, Inc., 3,084,324 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
9.97%
Shares
3,084,324
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P5.40%1,589,495
BVF I GP LLC5.40%1,589,495
BIOTECHNOLOGY VALUE FUND II LP4.40%1,289,734
BVF II GP LLC4.40%1,289,734
Biotechnology Value Trading Fund OS LP0.60%158,606
BVF Partners OS Ltd.0.60%158,606
BVF GP HOLDINGS LLC9.40%2,879,229
BVF PARTNERS L P/IL9.97%3,084,324
BVF INC/IL9.97%3,084,324
LAMPERT MARK N9.97%3,084,324

Source

View original at SEC

Related